You are currently viewing a new version of our website. To view the old version click .

HPV in the Young Population: New Perspectives in Clinical Practice from Vaccination to Screening

This special issue belongs to the section “Human Papillomavirus Vaccines“.

Special Issue Information

Dear Colleagues,

The introduction of HPV vaccination can prevent the development of HPV-related diseases of the genital tract. Ideally, young people should receive the vaccine before becoming sexually active. Those who are already sexually active may still benefit from immunization, since few young people are infected by all HPV strains. It is important to understand the natural history of HPV infection in order to understand the impact of infection on this population. This understanding can help promote vaccination and adherence to screening programs.

This Special Issue covers all topics related to HPV in clinical practice from vaccination to screening, and focuses on studies examining the significance of vaccines/therapeutic vaccines in the management of disease. Manuscripts of different types, including long comprehensive research articles or reviews, will be considered for publication in this Special Issue. All submissions will undergo rigorous peer review.

Dr. Mattia Dominoni
Dr. Lucia Merlino
Dr. Barbara Gardella
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HPV
  • younger people
  • vaccination
  • cervical intraepithelial neoplasia (CIN)
  • experimental HPV vaccines
  • therapeutic HPV vaccines

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X